A series of 102 newly referred and uninfected patients on whom 299 operative procedures to insert ventriculoauricular cerebrospinal fluid shunts were performed over a 12-year period were studied for the rate and cause of associated sepsis. It was found that 15.7% of the shunt insertions were followed by infection, and 1.3% of the revisions, for an overall infection rate of 14%. There were two clinical groups, those who developed acute postoperative infections (9%) and those with delayed infections developing 1 month to 6 years after operation (5%). The causes of the infections are discussed. It is suggested that careful follow-up with frequent blood cultures will reveal more infected cases in the delayed group, and that bacteriocidal agents selected for the specific organism should be maintained in cerebrospinal fluid and blood for long periods. Despite reports of an incidence of from 6% to 23% in a number of series, 2'5'7,1~176 no accurate estimate exists for a postoperative infection rate in a patient group closely observed over a long period of time2 Our experience over a 12-year period with 299 operative procedures in 102 newly referred and uninfected patients (age 1 day to 37 years) suggests that infection is a more serious complication than has been appreciated.
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Clinical Method
From 1957 to 1969, 132 patients suspected of having hydrocephalus were referred to the University of Washington neurosurgical or pediatric service and seen by one or both of the senior authors. Six patients with preoperative purulent cerebrospinal fluid as well as 24 with previous shunt infections have been excluded from this study.
From our earliest recognition of the importance of associated sepsis, 31 we have kept records of possible contributory pre-and intraoperative factors. All variables have not been recorded for all 299 operations either because we had not yet recognized their significance or our records were incomplete. Hence, totals for individual variables in some tables do not always equal 299.
All patients were studied by routine clinical evaluation to establish etiological and anatomical diagnoses as well as the presence of complications? ~ Progressive hydrocephalus was identified by some combinations of the following findings: enlarging cranial circumference, tense nonpulsatile fontanel, papilledema, persistently elevated ventricular pressure without compensatory response to volume change, and enlarging ventricles (diminishing frontal mantle). 9,1~ Children with inactive or questionably progressive hydrocephalus were seen at 1-to 3-month intervals and restudied as indicated by the clinical course. Progressive hydrocephalus was treated by ventriculoauriculostomy with a Pudenz-Heyer valve, with or without a standard flushing device, a to-and-fro flushing device or a flushing device with a separate ventricular reservoir (V-A shunts). Double compartment hydrocephalus was treated with a proximal "Y" tube inserted into a single pump and/or distal cardiac limb system. Longer operative times than the 30-45 minutes reported by Forrest and Cooper 11 were necessary because diagnoses included intraoperative pressure studies' and related training of the house staff. Since 1960, frequent blood cultures for minimal clinical symptoms of pyrexia, malaise, failure to thrive, and anemia have been obtained. Prophylactic antibiotics were not used unless a focus of infection was identified preoperatively. Reinfections were identified by the isolation of different organisms after a symptom-free afebrile course without antibiotics between infections. A symptom-free period was not used alone because indolent infections have been known to persist for several months 11 to years 31 before symptomatic relapse.
Treatment of ventriculitis and septicemia frequently involved complete removal of existing shunt systems and replacement with closed ventriculostomy, ventriculomastoidostomy, ventriculoperitoneostomy, or ventriculoureterostomy. All these alternate systems proved to be temporary. Thirteen clean V-A shunts were subsequently placed in 11 previously infected patients. These clean repeat V-A shunts will be considered in our analysis as new uninfected V-A shunts.
Results
There were 115 VA shunts and 184 revisions in 102 patients. Of the 115 V-A shunt insertions, 18 (15.7%) were followed by infection; of the 184 revisions, 24 (1.3%) were associated with infection (Table 1) . Overall, 14% of the insertions and revisions were followed by infection. The small number of cases with multiple operations gives a wide variation that is not statistically significant (x 2 --0.67; p = 0.3-0.5).
Further analysis of the postoperative infection rate (Table 1) reveals two clinical groups: the acute and the delayed groups. Group 1 patients had postoperative symptoms of fever within a 3-day period; confirmatory positive blood cultures were frequently obtained much later. Because we performed routine cultures postoperatively, some patients had culture evidence of infection before symptoms developed. Low-grade evening fever was uniformly present within 4 weeks. The over-all incidence of acute postoperative infection was 9%, being 10% for insertions and 2% to 14% for revisions. Group 2 patients had delayed shunt infections; they were symptom-free and "culturefree" without antibiotics for 1 month to 6 years postoperatively before developing signs of sepsis. The over-all rate of delayed shunt infection was 5%, being 5% for insertions and 5% for revisions. Our acute postoperative infection rate of 9% and the total infection rate of 14% fall within the range of 6% to 23% reported by others. 2, 5, 7, 10, 11, 20, 21, 23, [29] [30] [31] [32] 36, 38 A total of 27 of the 102 patients (27%) experienced an acute postoperative infection, a ratio that is higher than the acute postoperative insertion infection rate of 10% (12 infections following 115 procedures).
Of the 90% uninfected shunt patients, 19 % acquired infection with a second procedure (V-A shunt revision 1) ; therefore, 17% (19% of 90%) of the original 102 patients at risk would theoretically acquire infection if all were required or lived to undergo a revision. Hence, 27% of all patients undergoing a V-A shunt insertion and one revision had acquired an infection (Fig. 1) . Using a similar reasoning for those patients experiencing a third and fourth revision (Table 2), we observed an infection rate of 3 % (2% of the original population theoretically at risk) and an accumulative rate of 29%. The 17% of the patients acquiring an infection during revisions 4 through 11 represent 12% of the "at-risk" population (17% of 71% of uninfected patients) for an accumulative "at-risk" patient infection rate of 41% (15) .
As might be expected, those patients with one shunt infection who subsequently had a replacement of a V-A shunt experienced a similar operative infection risk and had two or more septic episodes ( Table 3) .
Analysis of our data for factors contributing to infection revealed only three significant relationships. First, thrombus formation in the right side of the heart or vena cava was seen more frequently with infection or following cured infections than with uninfected shunts (p ~ 0.001; f Exclusive of delayed or repeat infections. :~ The numbers of patients undergoing revisions 2 and 3 and 4-11 have been grouped because of the relatively small numbers of patients living sufficiently long or requiring such treatment. Reasons for dropping out of the group undergoing shunt revision are death, acquisition of infection with V-A shunt insertion (10%), a professional or parental decision to defer further active therapy, adequately functioning shunt, and inclusion in the study at such a recent date that the patient is too young.
wound over a shunt, was significantly related to infection (p = < 0.001, Tables 4 and  5 ).~ Third, exclusive of the myelodysplasia group there was a significantly higher shunt infection rate for patients with adhesive arachnoiditis and congenital brain cysts ( Table 
No statistically significant differences in shunt infection rate were observed under any of the following circumstances: a break in surgical technique because of anesthetic difficulties, increased manipulation, difficult neck dissections, ventricular catheter adjustments, urinary tract sepsis, order of scheduling in a general operating theater, existence of prior infection in the central nervous system, duration of the operation, the type of PudenzHeyer system used, the number of surgical assistants, the type of preoperative skin preparation (Table 6 ), or variation in the resident team.
Preoperative diagnostic procedures that involved puncture of the central nervous system membranes were followed by infection in six children. Preoperative diagnostic procedures could potentially introduce indolent infection infection that does not become evident until after a subsequent shunt. The difference in number of studies preoperatively in our infected and uninfected groups was insignificant qualitatively and quantitatively (Table   7) .
Discussion
During the first 5 years of our project we compared our operative cases to a control group. TM Since that time we have treated all patients aggressively for three reasons. First, we and others have established the value of a V-A shunt for prolonging life for hydrocephalic children.~,~,l~176 2s Second, we wished to correlate preoperative variables with ultimate prognosis. Third, with more routine cases being treated in the commu- (126) includes all patients with sufficient data for this analysis. t Five patients experienced at least two different post-shunt infections. :~ Some operations were performed on patients who experienced subsequent shunt revision followed by infection (see Table 2 ).
w The relatively lower rates of infection for idiopathic congenital communicating, communicating and obstructive with myelodysplasia, and the various types of obstructive (exclusive of brain cysts) hydrocephalus is real (x2= 120: p = <0.001).
nity, the number of our referred cases has become progressively less representative of the general population of hydrocephalic patients. The latter is illustrated by the complex post-shunt problems now being sent to us, 11 of the last 24 (45%) were referred with infected shunts in situ.
Our observations suggest that a portion of the postoperative V-A shunt infections can be attributed to intraoperative infections. Previous operating room studies have implicated intraoperative air contamination as contributory to wound sepsis 18,17,2m7 and particularly to cardiac prosthesis infection ~,25,28 and V-A shunt sepsis? 1,12,23 Despite our own suspicions, we have been unable to prove from this study that longer, more difficult procedures with more tissue exposure and trauma are associated with a higher infection rate (Table 6 ). Modifications in technique to prevent infection may, at great cost, reduce operative infections to a minimal level of 4% to 6% .1,12 In our series of cases, close surveillance and frequent blood cultures have detected a disappointingly high rate of infection, despite precautions. Unsuspected indolent infections can precipitate sudden death and have been associated, perhaps causally, with thrombus formation (Table 4). Thrombo-embolism, benign or septic, can cause death from failure of the right side of the heart. One such complication occurred in our series, a child with Escherichia coli sepsis, untreated for 18 months.
Further decrease in CNS infection and shunt contamination can be achieved by early closure of open myelodysplastic sacs 4 and shunt-associated dehiscence or decubiti (Table 4) . 5 Others have viewed the problems of increased central nervous system infection, myelodysplasia repair breakdown, and V-A shunt before or after back repair p=0.8-.7
with differing opinions? ,~3 The high incidence of central nervous system infection with myelodysplasia TM warrants a separate approach to the problem of the child with hydrocephalus and "open" myelodysplasia. If closed, there is no difference in the shunt infection rate for children with associated myelodysplasia and other types of hydrocephalus (Table 6 ). The sudden onset of ventriculitis meningitis or septicemia in 5 % of our Group 2 patients 1 month to 6 years after their last operative procedure suggests that shunt infections can occur as a result of "normal bacteremia." Seeding of infection by a foreign body in the right side of the heart or thrombus then develops into chronic sepsis.
Central nervous system infection occurred more often in our patients with closed and treated hydrocephalus, than in "normal" infants and children. 14 For example, one child developed symptoms of acute infection 5 months after the last surgery; Hemophilus influenzae was grown from the blood and cerebrospinal fluid. Another child developed septic signs with high fever and scarletina 3 months after the last revision; Beta Hemolytic streptococcus was grown from the cere- brospinal fluid, shunt, and blood. This child, however, developed shunt obstruction and right heart thrombosis, and eventually Staphylococcus aureus was isolated from the blood. Cure in both these children followed standard parenteral antibiotic therapy as for any meningitis case in "normal" children. A third patient developed chills and fever in recurrent bouts of sudden onset 6 years after the last operative procedure; the blood also grew Staphylococcus aureus. Both patients with S. aureus septicemia responded to antibiotics parenterally during complete shunt removal.
In reporting a 5 % delayed infection rate (Table 1) and implying nonoperative infection, we have been careful to include only obvious cases. There are a number of children classified in our 9 % acute operative infection group who illustrate the difficulty in recognizing indolent infection. One child experienced acute recurring bouts of fever beginning in the immediate postoperative period; urinary tract infection was identified but 3 years later Staphylococcus epidermidis was grown from her blood. Another child had a thrombo-embolism, negative blood cultures, and recurrent fevers for 2 years postoperatively. The febrile episodes were associated with upper respiratory symptoms, particularly otitis media. Staphylococcus aureus was eventually isolated from her blood. Because both of these children had the onset of symptoms shortly after operation, and despite negative cultures from the blood for months, we have classified them as acute postoperative infections.
Regardless of the origin of the infection, we have established the tendency for shortterm analysis, to give a low patient infection rate of 10% 10 similar to our acute postoperative infection rate of 9% (Table 2) . Our long-term study suggests an accumulative case infection rate of 41% (Table 3 and Fig.  1 ). The small number of children surviving long enough to undergo 5 to 12 revisions provides us with only tentatively reliable data. Four other studies for shorter followup periods contain similar data, however. Anderson 2 reported an operative infection rate of 12.5% and a case infection rate of 22%; Yashon and Sugar 38 reported 8.5% and 14%, Overton and Snodgrass 23 reported 5.8% and 13%, and Sayers 29 reported 9% and 23%. Larger series reported operative infection rates of 19/300 (6.3%),~ and sep-tic death rates of 3/166 (2%).12 The largest group followed for the longest 1I had a case infection rate of 11%, with a higher rate for older cases (16%) than for the younger ones (8%). Smaller more intensely studied series report higher infection rates of 19% to 22%. 3, 20, 30 We interpret the wide spectrum of sepsis rates associated with V-A shunts to he due only partially to a more careful search for bacteria in those studies with a higher incidence.
Time is a more important factor in those studies reporting a higher infection. Whereas the operative infection risk remains relatively constant, the longer a patient lives the greater becomes the chance for him to need a shunt revision. Since we find it necessary to revise V-A shunts to accommodate for growth and relieve obstruction throughout the life of most of our patients, TM a patient population undergoing repetitive procedures should experience a rising patient case infection rate. Such an interpretation explains the differences in operative and case infection rates noted by most authors and suggests that, with the passage of time, each population of shunt-dependent patients will have an increasing case infection rate.
Conclusions
On the basis of our experience we emphasize four factors to explain an accumulative case infection rate: 1) repeated exposure to a 9% acute postoperative infection risk; 2) primary right auricle thrombosis with eventual secondary indolent infection from "normally asymptomatic" bacteremia; 3) increased susceptibility of the hydrocephalic patient to nonoperative acute and virulent central nervous system infections; and 4) infection entry into the central nervous system or shunt via openings in the central nervous system (myelodysplasia or scalp decubiti) or skin (wound dehiscence or decubiti).
Careful follow-up with frequent blood cultures will reveal more infected cases. Prevention and treatment can then be directed by the nature of the infection and the susceptibility of the organism. Bacteriocidal agents, selected after testing against the organism in vitro, should be maintained in cerebrospinal fluid and blood for long periods. Consideration should be given to removal of infected shunts and intrathecal therapy when indicated by cerebrospinal fluid antibiotic levels and persistent infection. 6,~z,~9,3~,33
